$Based on the seminar materials of the “Oncohematology” Journal Experts Council “Modern approaches to the refractory multiple myeloma treatment”$

Based on the seminar materials of the “Oncohematology” Journal Experts Council “Modern approaches to the refractory multiple myeloma treatment”

.

Bibliographic Details
Main Author:	S. V. Semochkin
Format:	Article
Language:	Russian
Published:	ABV-press 2021-11-01
Series:	Онкогематология
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/510

Similar Items

Treatment of double-refractory multiple myeloma
by: S. V. Semochkin
Published: (2021-09-01)

Pomalidomide in the management of relapsed/refractory multiple myeloma: A review
by: Sergej Semochkin
Published: (2023-08-01)

Advances and perspective of the immunotherapy for relapsed/refractory multiple myeloma (interview)
by: S. V. Semochkin
Published: (2022-01-01)

Long-term continuous treatment as a new strategy for relapsed or refractory multiple myeloma
by: S. V. Semochkin
Published: (2020-07-01)

Pomalidomide for the management of relapsed and refractory multiple myeloma: a case report and review of literature
by: S. V. Semochkin
Published: (2015-10-01)

Ixazomib in the treatment of relapsed multiple myeloma
by: S. V. Semochkin
Published: (2018-07-01)

Expert Council resolution on the specifics of multiple myeloma therapy during COVID-19 pandemic
by: Article Editorial
Published: (2020-07-01)

Biological basis of immunomodulatory preparations using in treatment of multiple myeloma
by: S. V. Semochkin
Published: (2022-11-01)

New proteasome inhibitors in the management of multiple myeloma
by: S. V. Semochkin
Published: (2019-07-01)

According to the materials of the Conference “Algorithms of emergency situations in oncohematology. Approaches and treatment”
by: Yu. E. Ryabukhina
Published: (2022-07-01)

Pioneers of modernity in Ciudad Juarez: Chapel of the council seminar
by: Leticia Peña Barrera
Published: (2022-11-01)

Lenalidomide for the treatment of relapsed and refractory multiple myeloma
by: van de Donk NW, et al.
Published: (2012-08-01)

Lenalidomide for relapsed or refractory multiple myeloma
by: S. S. Bessmeltsev1, et al.
Published: (2014-07-01)

Lenalidomide for relapsed or refractory multiple myeloma
by: S. S. Bessmeltsev1, et al.
Published: (2014-07-01)

THE RESOLUTION OF THE EXPERT COUNCIL FOR TARGETED THERAPY OF RADIOIODINE REFRACTORY DIFFERENTIATED THYROID CANCER
by: . Expert Council
Published: (2015-04-01)

Use of biological microarrays in oncohematology
by: T. V. Nasedkina
Published: (2022-11-01)

The role of pomalidomide in treatment of relapse and refractory multiple myeloma
by: S. V. Voloshin, et al.
Published: (2022-01-01)

Proceedings of the Seminar on telecommunication council
by: 402226 Seminar on Pacific Telecommunication Council (8th : 1986 : Honolulu, Hawaii)

Prevention and treatment of thrombosis in cancer and oncohematological patients
by: O. V. Somonova, et al.
Published: (2021-11-01)

Trends in the treatment of cytomegalovirus infection in oncohematological patients
by: D. N. Balashov
Published: (2014-07-01)

Trends in the treatment of cytomegalovirus infection in oncohematological patients
by: D. N. Balashov
Published: (2014-07-01)

Kidney involvement in monoclonal gammopathies: multidisciplinary approach in oncohematology and nephrology
by: A. V. Smirnov, et al.
Published: (2020-07-01)

The multicenter experience with bendamustine in the treatment of relapsed and refractory multiple myeloma
by: S. V. Voloshin, et al.
Published: (2015-10-01)

Observation of oncohematologic patients by general pediatricians
by: S. R. Varfolomeyeva, et al.
Published: (2022-11-01)

INVASIVE ASPERGILLOSIS AND MUCORMYCOSIS IN ONCOHEMATOLOGICAL PATIENTS
by: O. V. Shadrivova, et al.
Published: (2018-07-01)

Characteristics of HCV infection in oncohematological patients
by: D. A. Lioznov, et al.
Published: (2020-03-01)

Biosensors in Clinical Practice: Focus on Oncohematology
by: Agostino Cortelezzi, et al.
Published: (2013-05-01)

Relapsed/Refractory Multiple Myeloma in 2020/2021 and Beyond
by: Klaus Podar, et al.
Published: (2021-10-01)

How to Manage Patients with Lenalidomide-Refractory Multiple Myeloma
by: Felipe de Arriba de la Fuente, et al.
Published: (2022-12-01)

How I treat relapsed and/or refractory multiple myeloma
by: Hans C. Lee, et al.
Published: (2020-09-01)

RELAPSED/REFRACTORY MULTIPLE MYELOMA: THE CURRENT STATE OF PLAY
by: María-Victoria Mateos, et al.
Published: (2015-07-01)

Prevention and management of bortezomib-induced peripheral neuropathy in patients with multiple myeloma
by: S. V. Semochkin, et al.
Published: (2022-04-01)

Modern therapy of multiple myeloma
by: O. M. Votyakova
Published: (2008-12-01)

Monoclonal Antibodies: Leading Actors in the Relapsed/Refractory Multiple Myeloma Treatment
by: Sonia Morè, et al.
Published: (2020-11-01)

PHARMACOECONOMIC EVALUATION OF POMALIDOMIDE (IMNOVID) FOR THE TREATMENT OF RECURRENT AND REFRACTORY MULTIPLE MYELOMA
by: M. Yu. Frolov, et al.
Published: (2017-08-01)

Towards Understanding the Pathogenicity of DROSHA Mutations in Oncohematology
by: Dmitrii S. Bug, et al.
Published: (2021-09-01)

MUCORMYCOSIS IN ONCOHEMATOLOGY PATIENTS (results of the prospective study)
by: N. N. Klimko, et al.
Published: (2017-06-01)

COMBINATION OF INVASIVE ASPERGILLOSIS AND MUCORMYCOSIS IN ONCOHEMATOLOGICAL PATIENTS
by: O. V. Shadrivova, et al.
Published: (2018-02-01)

Microarrays: a new era in development of oncohematology
by: Ye. A. Nikitin, et al.
Published: (2022-11-01)

Bioethical aspects of palliative care to patient oncohematologic
by: Olga Lidia Alonso Mariño, et al.
Published: (2015-03-01)